What is DA Davidson’s Forecast for USNA Q4 Earnings?

USANA Health Sciences, Inc. (NYSE:USNA) – Research analysts at DA Davidson issued their Q4 2024 earnings estimates for shares of USANA Health Sciences in a research report issued to clients and investors on Wednesday, October 23rd. DA Davidson analyst L. Weiser expects that the company will earn $0.49 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $35.00 target price on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.50 per share.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.80%. The company had revenue of $200.22 million for the quarter, compared to analyst estimates of $208.45 million. During the same quarter in the prior year, the business posted $0.59 EPS.

Separately, StockNews.com downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 24th.

USANA Health Sciences Trading Down 2.6 %

NYSE USNA opened at $36.81 on Friday. The company has a fifty day simple moving average of $37.90 and a 200 day simple moving average of $42.41. The company has a market cap of $701.27 million, a P/E ratio of 11.47, a P/E/G ratio of 1.15 and a beta of 0.89. USANA Health Sciences has a 1 year low of $34.15 and a 1 year high of $54.81.

Insider Transactions at USANA Health Sciences

In other news, insider Paul A. Jones sold 6,266 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Paul A. Jones sold 6,266 shares of the stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total transaction of $240,489.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Gilbert A. Fuller sold 674 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total transaction of $26,751.06. The disclosure for this sale can be found here. In the last three months, insiders sold 7,940 shares of company stock valued at $311,670. Company insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On USANA Health Sciences

Several hedge funds and other institutional investors have recently added to or reduced their stakes in USNA. BOKF NA increased its position in USANA Health Sciences by 274.5% in the 1st quarter. BOKF NA now owns 2,771 shares of the company’s stock valued at $133,000 after acquiring an additional 2,031 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of USANA Health Sciences by 9.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock worth $284,000 after buying an additional 494 shares during the last quarter. Exchange Traded Concepts LLC raised its stake in shares of USANA Health Sciences by 4.4% during the third quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock worth $292,000 after buying an additional 322 shares during the last quarter. SG Americas Securities LLC acquired a new position in USANA Health Sciences in the second quarter valued at approximately $340,000. Finally, DGS Capital Management LLC boosted its stake in USANA Health Sciences by 61.8% in the first quarter. DGS Capital Management LLC now owns 7,258 shares of the company’s stock valued at $352,000 after acquiring an additional 2,773 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.